Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOINQUIRE
Bogart, Georgia, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
BioInquire was a bioinformatics software company that developed advanced tools for proteomics and mass spectrometry data analysis. Its flagship product, ProteoIQ, provided a comprehensive suite for the entire proteomic data analysis pipeline, including statistical validation and quantification. The software was designed to help researchers in academic, pharmaceutical, and biotechnology laboratories derive meaningful insights from complex proteomic and glycomic experiments. Founded in 2007 as a spin-off from the University of Georgia, BioInquire was acquired by the Australian biotechnology company NuSep Holdings in 2010. In 2013, the intellectual property for ProteoIQ was sold to PREMIER Biosoft.
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on BIOINQUIRE.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOINQUIRE.